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Abstract 
 
The fruit fly, Drosophila melanogaster, has proved to be a useful model organism for studying 
the biology of neural stem cells.  Notably, significant progress has been made in identifying the 
molecular mechanisms that regulate the asymmetric cell divisions of the neural stem cell-like 
neuroblasts during brain development.  Recently, the emerging technology of genome-wide 
transgenic RNA interference (RNAi), which makes it possible to analyze complicated 
developmental processes in a targeted, tissue-specific way, has been used for the analysis of gene 
function in Drosophila neuroblasts.  Here, we review the key molecular mechanisms that regulate 
the asymmetric cell divisions of neuroblasts during brain development in Drosophila.  We then 
summarize recent genome-wide transgenic RNAi screens in Drosophila and report on the 
identification of new regulators and gene networks that are required in balancing neuroblast self-
renewal and differentiation. 
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Highlights 
 
Neuroblasts are neural stem cells in the Drosophila brain. 
Cell fate determinants control self-renewal and differentiation of neuroblasts. 
Genome-wide transgenic RNAi identify new genes regulating neuroblasts proliferation. 
Drosophila neuroblasts are a new model to study cancer stem cells. 
 
 
 
 
 
Abbreviations used: aPKC, atypical PKC; Brat, Brain tumor; GMC, ganglion mother cell; INP, 
intermediate neural progenitor; Insc, Inscuteable; lgl, lethal (2) giant larvae; Loco, Locomotion 
defects; Mud, Mushroom body defect; Pins, Partner of inscuteable; Pon, Partner of Numb; Pros, 
Prospero; RISC, RNA-induced silencing complex; RNAi, RNA interference; TRiP, Transgenic 
RNAi Project; VDRC, Vienna Drosophila RNAi Center. 
 
 
 
 
Introduction 
 
The central nervous system in both vertebrates and invertebrates comprises complex networks of 
neuronal circuits.  The neural cells that make up these networks are derived from neural stem 
cells, which have the ability to self-renew and to give rise to differentiated neuronal and glial 
progeny through asymmetric and proliferative cell divisions.  Balancing self-renewal and 
differentiation of neural stem cells is essential during development, because dysregulation of 
genes controlling asymmetric cell division can cause severe developmental defects, and 
furthermore, lead to the formation of brain tumors [1-3]. 
In the past two decades, the fruit fly, Drosophila melanogaster, has proved to be a powerful 
model organism for studying the biology of neural stem cells [4-7].  Drosophila neural stem cells 
are called neuroblasts for historical reasons.  Many important genetic elements and signaling 
pathways that regulate the asymmetric cell divisions of Drosophila neuroblasts have been 
characterized and analyzed in great detail [5,8,9].  However, our understanding of the molecular 
and cellular mechanisms controlling self-renewal and differentiation of Drosophila neuroblasts is 
still incomplete. 
Recently, significant progress in analyzing these mechanisms has been attained through the use 
of genome-wide RNA interference (RNAi) for the identification and functional analysis of genes 
involved in neuroblast proliferation in the developing brain.  This has been possible due to the 
generation and availability of several independent genome-wide transgenic RNAi libraries, which 
are based on the binary Gal4/UAS expression system that allow analysis of complicated 
developmental processes in a targeted, tissue-specific way [10-13]. 
In this review, we focus on the biology of Drosophila neuroblasts and summarize the key 
molecular mechanisms that regulate the asymmetric cell divisions of these neuroblasts during 
brain development.  We then introduce recent genome-wide RNAi screens in Drosophila.  
Finally, we review the application of genome-wide transgenic RNAi in the analysis of self-
renewal and differentiation of Drosophila neuroblasts and report on the identification of new 
regulators and gene networks that are required in balancing neuroblast self-renewal and 
differentiation. 
 
Neural stem cells in Drosophila 
 
Neuroblasts, the neural stem cells in Drosophila, have the characteristic feature of the neural 
stem cells in vertebrates, namely to divide asymmetrically to self-renew while generating a wide 
range of more differentiated progeny [3-7].  In Drosophila, neuroblasts give rise to differentiated 
neurons and glia cells in the central brain, optic lobes, and ventral nerve cord [14].  In this 
review, we will focus primarily on the mechanisms that underlie the specification and 
homeostasis of the neuroblasts in the central brain; similar mechanisms have been shown to 
operate in the neuroblasts of the optic lobes and ventral nerve cord, which have been recently 
reviewed elsewhere [3,5,6]. 
In Drosophila, neurogenesis starts during early embryonic development [15].  In the embryonic 
neuroectoderm, groups of cells acquire the potential to become neuroblasts by expressing 
proneural genes, such as the genes of the achaete-scute complex and daughterless (Fig. 1A) 
[15,16].  From each of these equivalence groups a single cell is selected to become a neuroblast 
through a process called “lateral inhibition”, which is mediated by the Notch signaling (Fig. 1A) 
[16].  The specified neuroblasts enlarge in size, delaminate basally from the neuroectoderm and 
then go on to divide asymmetrically along their apical-basal axis in a stem cell-like manner (Fig. 
1A) [6,7]. 
In the developing brain, neuroblasts undergo two phases of proliferation.  The first takes place 
during embryogenesis, and the neuroblasts only go through a limited number of cell divisions to 
generate the primary neurons of the larval brain [14,17,18].  After a quiescent phase at the end of 
embryogenesis, most of the brain neuroblasts reinitiate proliferation in a second phase of 
neurogenesis during larval development to produce numerous secondary neurons in the adult 
brain [18-21].  These secondary neurons make synaptic interconnections and form adult-specific 
neuropile structures during pupal development [18,22].  The clonal unit generated by a 
neuroblast, consisting of primary neurons as well as secondary neurons, is referred to as the 
neuroblast’s lineage [18,22,23]. 
Approximately 100 neuroblasts have been identified in each hemisphere of the Drosophila brain, 
and these can be divided into two types (Fig. 1B) [7,8,24-27].  The type I neuroblasts, which 
constitute the majority of the brain neuroblasts, divide in a simple way.  During each division, 
type I neuroblasts give rise to a larger daughter cell, the renewed neuroblast, and a smaller 
daughter cell called a ganglion mother cell (GMC).  Each GMC divides only once to generate 
two postmitotic cells that further differentiate into neurons or glia cells (Fig. 2A) [7,8,24].  
Recently, a second type of neuroblast, termed a type II neuroblast, has been identified in the 
Drosophila brain [25-27].  Unlike type I neuroblasts, there are only eight type II neuroblasts in 
each brain hemisphere.  Six type II neuroblasts localize at the dorsomedial edge of the posterior 
brain lobe, and the other two are formed at a more lateral position (Fig. 1B) [25-27].  In contrast 
to type I neuroblasts, the type II neuroblasts divide in a more complex way to self-renew and to 
give rise to an intermediate neural progenitor (INP) cell, which undergoes several rounds of cell 
division, each of which results in self-renewal of the INP and in the generation of a GMC that 
further produces two progeny (Fig. 2B) [25-27].  Because of the amplification of proliferation 
through the divisions of INP cells, a significant increase in neural cell number occurs in type II 
neuroblast lineages.  Thus, whereas most type I neuroblast lineages consist of approximately 100 
to 150 neurons, type II neuroblasts typically give rise to lineages that are 3 to 5 times larger [25].  
In addition, to counter-balance the amplification of proliferation, excess neurons in type II 
lineages are eliminated through programmed cell death, a process that is essential for the correct 
neuropile innervation in the adult brain [28]. 
 
Asymmetric cell divisions of Drosophila neuroblasts 
 
Stem cell divisions in Drosophila, as in other animals, can be controlled by cell-intrinsic as well 
as cell-extrinsic mechanisms, to generate two daughter cells with different cell fates [29].  While 
the extrinsic regulation of stem cell division has been well-studied in the fly ovaries [30], the 
asymmetric cell divisions of the neuroblasts appear to be controlled primarily by cell-intrinsic 
regulatory mechanisms [8,31].  This intrinsic regulation of asymmetric neuroblast divisions is 
achieved by the asymmetric localization of a number of cell fate determinants within the 
neuroblast during mitosis and subsequently by the segregation of these proteins into only one of 
the two daughter cells [8,31].  During mitosis, two protein complexes are formed on opposite 
sides of the neuroblast.  On the apical side, the proteins Bazooka, Par-6, atypical PKC (aPKC), 
Inscuteable (Insc), Partner of inscuteable (Pins), Gαi, Locomotion defects (Loco), and Mushroom 
body defect (Mud) form an apical complex; whereas on the opposite basal side, the cell fate 
determinants Brain tumor (Brat), Prospero (Pros), and Numb, as well as two adaptor proteins 
Miranda and Partner of Numb (Pon) are localized in a basal complex [8,31]. 
In the apical complex, Bazooka, Par-6 and aPKC constitute the Par complex, which already 
localizes to the apical cortex during interphase and establishes the apical-basal polarity in the 
neuroblast [32-36].  The Pins, Gαi, Loco, and Mud proteins are linked to the Par complex through 
Insc and are required for spindle orientation [37-45]. Although all three proteins of the Par 
complex are preferentially segregated into the new neuroblast after cell division, and mutations in 
any of them affect the localization of the other apical proteins and the spindle orientation, the Par 
complex does not seem to control cell fate directly [8].  Instead, these proteins are thought to 
exert their function by inducing and restricting cell fate determinant proteins to localize to the 
basal side of the dividing neuroblast [8]. 
In Drosophila, three cell fate determinants, Brat, Pros, and Numb, have been characterized and 
studied in some detail [5-8].  All three proteins asymmetrically localize to the basal cortex during 
neuroblast division and subsequently are inherited only by the smaller GMC.  In the GMC, these 
proteins are thought to play two essential roles: first, to inhibit cell proliferation by suppressing 
the expression of neuroblast-specific genes and promoting cell cycle exit; second, to trigger cell 
differentiation by activating a neural cell differentiative program [5-8].  Numb is a membrane-
associated protein and it suppresses the Notch signaling pathway in the GMC [46,47].  Pros is a 
homeodomain containing transcription factor that is asymmetrically segregated into the GMC 
where it enters the nucleus and activates or represses more than 700 target genes that may be 
required for neuronal differentiation [48-51].  Brat is a RNA-binding protein that negatively 
regulates cell growth and ribosomal RNA synthesis [52-55].  Mutations in any of the three 
determinant genes result in the overproliferation of the neuroblasts and the formation of brain 
tumors [53-57].  The observation of overgrowth and tumorigenesis in the mutant brains have 
recently made Drosophila neuroblasts an emerging model to study cancer stem cells (see below) 
[8,9,31].  
Although numerous studies have been made using classic genetic and molecular methods to 
investigate the functions of the three cell fate determinants in Drosophila neuroblasts, the 
complete gene networks controlled by these proteins in the regulation of neuroblast self-renewal 
and differentiation are still poorly understood [5-8].  To obtain insight into these gene networks, 
large-scale genome-wide transgenic RNAi technology has recently been used in order to identify 
novel genes that are potential regulators in the self-renewal and proliferation of Drosophila 
neuroblasts [12,13]. 
 
Genome-wide RNAi screens in Drosophila 
 
RNA interference (RNAi) is a cellular process that can sufficiently suppress (knock down) the 
expression of genes at the post-transcription level.  RNAi is mediated by the RNA-induced 
silencing complex (RISC) and short double-stranded RNA molecules that recognize their target 
genes in a sequence-specific manner [58,59].  These RNA molecules are either encoded 
endogenously (microRNAs, siRNAs) or introduced exogenously [60,61].  With the availability of 
a large number of genome sequences for different organisms, it is possible to construct RNAi 
libraries that target and silence every individual gene, thus facilitating large-scale genome-wide 
analysis of gene functions [10].  In the past decade, a variety of RNAi libraries have been 
generated and screens have been made using different cell cultures or model organisms including 
C. elegans, Planaria, and Drosophila. 
Early RNAi-based screens in Drosophila were mostly carried out in cultured cells, and a wide 
range of diverse biological processes have been studied in cell culture models [10].  To date, cell-
based RNAi screens have been used to identify new candidate genes in genetic networks such as 
those that regulate growth and viability [62], cell cycle [63], cell death [64], cell signaling [65], 
and host-pathogen interactions [66].  Although this type of screen has provided new findings for 
many basic cellular processes, it is not suitable for the analysis of more complex multicellular 
developmental processes that occur within the intact organism. 
In order to analyze complicated cellular and developmental processes in a tissue-specific manner 
in the intact animal, a second type of genome-wide screen has been developed which uses 
transgenic flies carrying RNAi transgenes that can be combined with the established Gal4/UAS 
binary expression system (Fig. 3) [67].  Currently, three independent sources of genome-wide 
UAS-RNAi transgenic lines are available [Vienna Drosophila RNAi Center (VDRC), Transgenic 
RNAi Project (TRiP) at the Harvard Medical School, and NGI-FLY RNAi Resources in Japan], 
such that altogether about 90% of the annotated genes in the Drosophila genome can now be 
targeted by these lines [67].  With the availability of these lines, genome-wide transgenic RNAi 
screens have been successfully used to study Notch signaling [68,69], muscle morphogenesis and 
functions [70], host-pathogen interactions [71], and self-renewal of neuroblasts [12,13].  Taken 
together, these studies show that even very complicated biological mechanisms can be 
systematically analyzed at the genome-wide level by transgenic RNAi. 
 
Transgenic RNAi analysis of neuroblast self-renewal and proliferation in Drosophila 
 
The suitability of large-scale genome-wide transgenic RNAi screens for the identification of 
candidate genes involved in the regulation of self-renewal and proliferation of Drosophila 
neuroblasts has been demonstrated in two recent reports [12,13].  In the first report, Knoblich and 
colleagues carried out a genome-wide RNAi screen to indentify genes that are involved in 
cytokinesis, cell growth, and differentiation in brain neuroblasts and their lineages (Fig. 4) [12].  
Knock-down of candidate genes was targeted to the neuroblasts by crossing each individual UAS-
RNAi line to the driver line insc-Gal4 that is expressed in both type I and type II neuroblasts (Fig. 
4A) [54].  In total, 17,362 RNAi lines were screened (corresponding to 89% of the Drosophila 
genome).  24.1% of the lines caused lethality and were further analyzed for brain phenotypes 
(Fig. 4B).  This screen identified about 600 candidate genes (832 lines) that cause an abnormal 
brain phenotype.  The genes were then divided into subgroups according to a set of phenotypic 
categories based on the similarities of the abnormalities in the number, size and shape of the 
neuroblasts or their daughter cells (GMC, INP, or the entire lineage).  For example, among these 
600 candidates, a subgroup of 29 genes caused an overproliferation phenotype, suggesting that 
they are required for restricting neuroblast self-renewal.  In addition, based on the annotated gene 
structure and the known or predicted molecular functions of the candidates, the authors also 
constructed gene networks using clustering algorithms.  In this manner, they identified all 
putative transcription factors and chromatin regulators that form a transcriptional network for 
neuroblast self-renewal and also defined genes that interact with known regulators of asymmetric 
cell divisions and thus form an asymmetric cell division regulatory network. 
In a second study, Doe and colleagues combined both transcriptional profiling analysis and 
transgenic RNAi knock-down experiments, again with the aim of characterizing genes that 
regulate neuroblast self-renewal in Drosophila [13].  Using microarray-based transcriptome 
analysis, the authors first studied six different Drosophila mutants, including brat and lethal (2) 
giant larvae (lgl), which are known to generate ectopic neuroblasts in the third instar larval 
brains.  By comparing the transcriptional profiling of these six mutants with wild-type, they 
identified around 1000 genes with elevated expression in the mutant brains, suggesting that they 
are likely to be expressed in neuroblasts and might be involved in neuroblast homeostasis.  To 
investigate the function of these genes, transgenic RNAi knock-down experiments were carried 
out in which UAS-RNAi lines were crossed with another neuroblast driver line, wor-Gal4 [72].  
This functional analysis yielded a list of 84 potential regulators for neuroblast self-renewal in 
Drosophila. 
The majority of genes identified in both of these screens are thought to promote neuroblast self-
renewal, as targeted knocking down of these genes generally showed an underproliferation 
phenotype (538 of 620 genes in [12], and 72 of 84 genes in [13]).  Furthermore, for the genes 
with an underproliferation phenotype, 46 genes were identified by both groups.  Interestingly, 
both screens identified a rather small number of genes for which RNAi knock-down resulted in 
an increase in the number of neuroblasts (18 in [12], and 12 in [13]).  However, among these, 
only two genes (miranda and Ssrp) were found by both groups.  The reason for this low degree of 
overlap between the two studies is not clear; differential expression patterns of the Gal4 driver 
lines, different genetic backgrounds of the fly strains used, as well as differences in the design of 
the two screens might be responsible, at least in part.  The altered expression of specific genes 
was also different among the mutants with ectopic neuroblast phenotypes (with elevated 
expression of a given gene in one mutant, but decreased expression of the same gene in another), 
underscoring the fact that proliferation control in neuroblasts is a highly complex process. 
In summary, these two recent transgenic RNAi screens have identified a large number of novel 
genes that appear to play important roles in controlling the balance between self-renewal and 
differentiation of Drosophila neuroblasts. Although the precise function of each of these genes 
needs to be validated using classical genetic methods, these studies indeed provide a valuable 
source of candidate genes for further analysis.  Moreover, since a large subset of the candidate 
genes identified in these screens have conserved orthologs in mammals, further analysis of these 
genes in murine models is likely to provide new insight into mammalian neural stem cell research 
as well. 
 
Drosophila neuroblasts as a model to study brain tumors 
The investigation of genes involved in the balance between neuroblast self-renewal and 
differentiation is important for understanding the mechanisms of neural stem cell action in 
normal brain development.  Moreover, there is an additional motivation for this type of research.  
In recent years, increasing evidence indicates that a small fraction of stem cells, or stem cell-like 
progenitor cells, might be the origin of certain cancers (cancer stem cells) including cancers of 
the brain [73].  However, the molecular mechanisms underlying normal and tumorigenic 
development in these stem cells are largely unknown.  Therefore, understanding how the balance 
between self-renewal and proliferation is disrupted in tumor stem cells at the cellular and 
molecular level is likely to be essential for future therapeutic implications both in tumor biology 
and in stem cell-based regenerative medicine [8,9]. 
A first Drosophila model for cancer study was established more than three decades ago, when it 
was shown that mutations in genes such as lethal (1) disc large, lgl, lethal (2) giant disc, and 
lethal (3) giant larvae can lead to malignant overproliferation in Drosophila brains or discs [74].  
More recently, comparable overgrowth phenotypes were also observed in brat, pros, and numb 
mutant brains, indicating that these cell fate determinants also act as tumor suppressor genes in 
Drosophila neuroblasts [53,55-57].  Indeed, the tumor suppressor function of genes involved in 
asymmetric cell division has been unequivocally demonstrated using a transplantation assay in 
which brain tissue from mutants of brat, pros, or numb transplanted into wild-type adult flies 
formed large malignant and metastatic tumors that eventually killed the hosts [75]. 
In view of these findings, it seems apparent that many other genes involved in neuroblast self-
renewal and differentiation may also act as tumor suppressors or oncogenes [9,75].  Thus an 
analysis of the potential role of the candidate genes involved in tumorigenesis from the recent and 
ongoing transgenic RNAi screens is likely to increase our mechanistic insight into the formation 
of brain tumors that derive from mutant neuroblasts.  Indeed, given that transgenic RNAi can be 
targeted to specific cells via Gal4 drivers and be activated or deactivated at specific times via 
Gal80 inhibitors, this emerging genetic technology seems to be ideally suited for investigating the 
molecular mechanisms underlying tumor formation and progression as well as tumor abrogation 
in the Drosophila neural stem cell model. 
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Figure Legends 
 
Fig. 1.  (A) Specification of the neuroblasts during development.  In the neuroectoderm, a group 
of cells acquire the potential to become a neuroblast by expressing proneural genes (green).  
Later, a single cell is selected to become a neuroblast through a Notch signaling mediated process 
called “lateral inhibition” (arrows).  The specified neuroblast enlarges in size, delaminates basally 
from the neuroectoderm and then divides asymmetrically along the apical-basal axis.  (B) 
Schematic representation of the Drosophila larval central nervous system, which consists of the 
central brain (CB), the optic lobes (OL), and the ventral nerve cord (VNC).  The CB contains two 
types of neuroblasts (NBs).  While the majorities are type I NBs (red), eight type II NBs are 
present in each brain hemisphere (blue). 
 
Fig. 2.  (A) Mode of cell division of type I neuroblasts.  The neuroblast (NB, pink) divides to 
self-renew and to give rise to a smaller ganglion mother cell (GMC, orange), which only divides 
once to generate two postmitotic neurons or glia cells (red).  (B) Mode of cell division of type II 
neuroblasts.  The neuroblast (NB, blue) divides to self-renew and to give rise to an intermediate 
neural progenitor cell (INP, light blue), which undergoes several rounds of cell division, each of 
which results in self-renewal of the INP and in the generation of a GMC (purple) that further 
produces two progeny (dark blue). 
 
Fig. 3.  Schematic representation of transgenic RNAi in Drosophila.  The driver line expresses 
the yeast protein Gal4, which is under the spatial and temporal control of a specific enhancer.  
The responder line contains an RNAi construct that is controlled by the UAS.  After crossing the 
two lines, Gal4 binds to UAS and leads to the transcription of the RNAi inverted repeat.  The 
RNA hairpins are further processed through the RNAi pathway to generate functional RNAi 
molecules, which results in the tissue-specific target gene knock-down.  
 
Fig. 4.  (A) Simplified workflow of the genome-wide transgenic RNAi screen in Drosophila 
neuroblasts [12].  The driver line co-expresses Dicer-2 to enhance the transgenic RNAi effect.  
Schematics show an overproliferative phenotype (left) and a normal brain (right).  (B) Summary 
of the primary screen in [12].  In total, 17,362 lines were screened and 24.1% (4,182 lines) 
resulted in lethality.  In these lethal lines, 832 showed abnormal brain phenotype. 
